Phage therapy against Enterococcus faecalis in dental root canals

References

• Gradmann C. Re-inventing infectious disease: antibiotic resistance and drug development at the Bayer Company 1945–80. Med Hist. 2016; 60: 155–80.
   PubMed Web of Science ®Google Scholar
• Gradmann C. Magic bullets and moving targets: antibiotic resistance and experimental chemotherapy, 1900–1940. Dynamis. 2011; 31: 305–21.
   PubMed Web of Science ®Google Scholar
• Price NL, Goyette-Desjardins G, Nothaft H, Valguarnera E, Szymanski CM, Segura M, etal. Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines. Sci Rep. 2016; 6: 24931.
   PubMed Web of Science ®Google Scholar
• Drusano GL, Louie A, MacGowan A, Hope W. Suppression of emergence of resistance in pathogenic bacteria: keeping our powder dry. Part 1. Antimicrob Agents Chemother. 2016; 60: 1183–93.
   Web of Science ®Google Scholar
• Drusano GL, Hope W, MacGowan A, Louie A. Suppression of emergence of resistance in pathogenic bacteria: keeping our powder dry, Part 2. Antimicrob Agents Chemother. 2016; 60: 1194–201.
   Web of Science ®Google Scholar
• O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015; 8: 217–30.
   PubMed Web of Science ®Google Scholar
• Yarlagadda V, Sarkar P, Samaddar S, Haldar J. A vancomycin derivative with a Pyrophosphate-Binding Group: a strategy to combat vancomycin-resistant bacteria. Angew Chem Int Ed Engl. 2016; 55: 7836–40.
   Web of Science ®Google Scholar
• Feng Y, Jonker MJ, Moustakas I, Brul S, Ter Kuile BH. Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics. Antimicrob Agents Chemother. 2016; 60: 4229–36.
   PubMed Web of Science ®Google Scholar
• Durai R, Ng PC, Hoque H. Methicillin-resistant Staphylococcus aureus: an update. Aorn J. 2010; 91: 599–606. quiz 7–9.
   PubMedGoogle Scholar
• Emami S, Nikokar I, Ghasemi Y, Ebrahimpour M, Sedigh Ebrahim-Saraie H, Araghian A, etal. Antibiotic resistance pattern and distribution of pslA Gene among biofilm producing Pseudomonas aeruginosa isolated from waste water of a burn center. Jundishapur J Microbiol. 2015; 8: e23669.
   Web of Science ®Google Scholar
• Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, etal. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011; 3: 55–65.
   PubMed Web of Science ®Google Scholar
• Bhinu VS. Insight into biofilm-associated microbial life. J Mol Microbiol Biotechnol. 2005; 10: 15–21.
   Web of Science ®Google Scholar
• Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev. 2009; 73: 310–47.
   PubMed Web of Science ®Google Scholar
• Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001; 45: 999–1007.
   PubMed Web of Science ®Google Scholar
• Romling U, Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med. 2012; 272: 541–61.
   PubMed Web of Science ®Google Scholar
• Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002; 8: 881–90.
   PubMed Web of Science ®Google Scholar
• Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35: 322–32.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15: 167–93.
   PubMed Web of Science ®Google Scholar
• Bradley CR, Fraise AP. Heat and chemical resistance of enterococci. J Hosp Infect. 1996; 34: 191–6.
   PubMed Web of Science ®Google Scholar
• Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002; 292: 107–13.
   PubMed Web of Science ®Google Scholar
• Aparna MS, Yadav S. Biofilms: microbes and disease. Braz J Infect Dis. 2008; 12: 526–30.
   PubMed Web of Science ®Google Scholar
• Schaudinn C, Gorur A, Keller D, Sedghizadeh PP, Costerton JW. Periodontitis: an archetypical biofilm disease. J Am Dent Assoc. 2009; 140: 978–86.
   Web of Science ®Google Scholar
• Ricucci D, Siqueira JF Jr. Biofilms and apical periodontitis: study of prevalence and association with clinical and histopathologic findings. J Endod. 2010; 36: 1277–88.
   PubMed Web of Science ®Google Scholar
• Nair PN. On the causes of persistent apical periodontitis: a review. Int Endod J. 2006; 39: 249–81.
   PubMed Web of Science ®Google Scholar
• Mohammadi Z, Soltani MK, Shalavi S. An update on the management of endodontic biofilms using root canal irrigants and medicaments. Iran Endod J. 2014; 9: 89–97.
   Google Scholar
• Pericas JM, Zboromyrska Y, Cervera C, Castaneda X, Almela M, Garcia-de-la-Maria C, etal. Enterococcal endocarditis revisited. Future Microbiol. 2015; 10: 1215–40.
   Web of Science ®Google Scholar
• Lebreton F, Willems RJL, Gilmore MS, Gilmore MS, Clewell DB, Ike Y, Shankar N. Enterococcus diversity, origins in nature, and gut colonization. Enterococci: from commensals to leading causes of Drug resistant infection. 2014; Boston: MA: Massachusetts Eye and Ear Infirmary. , PMID: 24649513.
   Google Scholar
• Palmer KL, van Schaik W, Willems RJL, Gilmore MS, Gilmore MS, Clewell DB, Ike Y, Shankar N. Enterococcal genomics. Enterococci: from commensals to leading causes of drug resistant infection. 2014; Boston: MA: Massachusetts Eye and Ear Infirmary. , PMID: 24649511.
   Google Scholar
• Ramsey M, Hartke A, Huycke M, Gilmore MS, Clewell DB, Ike Y, Shankar N. The physiology and metabolism of Enterococci. Enterococci: from commensals to leading causes of rug resistant infection . 2014; Boston: MA: Massachusetts Eye and Ear Infirmary. , PMID: 24649507.
   Google Scholar
• Agudelo Higuita NI, Huycke MM. Gilmore MS, Clewell DB, Ike Y, Shankar N. Enterococcal disease, epidemiology, and implications for treatment. Enterococci: from commensals to leading causes of rug resistant infection . 2014; MA: Massachusetts Eye and Ear Infirmary: Boston. , PMID: 24649504.
   Google Scholar
• Brito CS, Queiroz LL, Campos PA, Batistao DW, Silva Hde A, de Agostini GG, etal. The nares as a CA-MRSA reservoir in the healthy elderly. Rev Soc Bras Med Trop. 2015; 48: 614–16.
   Web of Science ®Google Scholar
• Coque TM, Patterson JE, Steckelberg JM, Murray BE. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J Infect Dis. 1995; 171: 1223–9.
   PubMed Web of Science ®Google Scholar
• Lowe AM, Lambert PA, Smith AW. Cloning of an Enterococcus faecalis endocarditis antigen: homology with adhesins from some oral streptococci. Infect Immun. 1995; 63: 703–6.
   PubMed Web of Science ®Google Scholar
• Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol. 2001; 67: 1628–35.
   PubMed Web of Science ®Google Scholar
• Baeten JM, McClelland RS, Overbaugh J, Richardson BA, Emery S, Lavreys L, etal. Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial. J Infect Dis. 2002; 185: 1187–91.
   PubMed Web of Science ®Google Scholar
• Theilacker C, Krueger WA, Kropec A, Huebner J. Rationale for the development of immunotherapy regimens against enterococcal infections. Vaccine. 2004; 22(Suppl 1): S31–8.
   Web of Science ®Google Scholar
• Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol. 2007; 56: 1581–8.
   PubMed Web of Science ®Google Scholar
• Guzman Prieto AM, van Schaik W, Rogers MR, Coque TM, Baquero F, Corander J, etal. Global emergence and dissemination of enterococci as nosocomial pathogens: attack of the clones?. Front Microbiol. 2016; 7: 788.
   Web of Science ®Google Scholar
• Sjogren U, Figdor D, Spangberg L, Sundqvist G. The antimicrobial effect of calcium hydroxide as a short-term intracanal dressing. Int Endod J. 1991; 24: 119–25.
   PubMed Web of Science ®Google Scholar
• Vivacqua-Gomes N, Gurgel-Filho ED, Gomes BP, Ferraz CC, Zaia AA, Souza-Filho FJ. Recovery of Enterococcus faecalis after single- or multiple-visit root canal treatments carried out in infected teeth ex vivo . Int Endod J. 2005; 38: 697–704.
   Web of Science ®Google Scholar
• Bystrom A, Sundqvist G. Bacteriologic evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy. Scand J Dent Res. 1981; 89: 321–8.
   PubMedGoogle Scholar
• Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, Solliday J, etal. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis . Antimicrob Agents Chemother. 1989; 33: 1588–91.
   PubMed Web of Science ®Google Scholar
• Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998; 4: 239–49.
   PubMed Web of Science ®Google Scholar
• Miller WR, Murray BE, Rice LB, Arias CA. Vancomycin-resistant enterococci: therapeutic challenges in the 21st century. Infect Dis Clin North Am. 2016; 30: 415–39.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157: 121–41.
   PubMed Web of Science ®Google Scholar
• Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012; 10: 266–78.
   PubMed Web of Science ®Google Scholar
• Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, etal. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008; 455: 804–7.
   PubMed Web of Science ®Google Scholar
• Park SY, Shin YP, Kim CH, Park HJ, Seong YS, Kim BS, etal. Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b. J Immunol. 2008; 181: 6328–36.
   Web of Science ®Google Scholar
• Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus . Microbiology. 2009; 155: 1749–57.
   PubMed Web of Science ®Google Scholar
• Sedgley C, Buck G, Appelbe O. Prevalence of Enterococcus faecalis at multiple oral sites in endodontic patients using culture and PCR. J Endod. 2006; 32: 104–9.
   Web of Science ®Google Scholar
• Liu H, Wei X, Ling J, Wang W, Huang X. Biofilm formation capability of Enterococcus faecalis cells in starvation phase and its susceptibility to sodium hypochlorite. J Endod. 2010; 36: 630–5.
   PubMed Web of Science ®Google Scholar
• Saleh IM, Ruyter IE, Haapasalo M, Orstavik D. Survival of Enterococcus faecalis in infected dentinal tubules after root canal filling with different root canal sealers in vitro . Int Endod J. 2004; 37: 193–8.
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Marchaim D, Palla M, Gudur UM, Pulluru H, Bathina P, etal. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study. Antimicrob Agents Chemother. 2013; 57: 49–55.
   Web of Science ®Google Scholar
• Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993; 37: 1563–71.
   PubMed Web of Science ®Google Scholar
• Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother. 1999; 43: 2161–4.
   PubMed Web of Science ®Google Scholar
• Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 1997; 41: 2016–18.
   PubMed Web of Science ®Google Scholar
• Palmer SM, Rybak MJ. Vancomycin-resistant enterococci. Pharmacotherapy. 1996; 16: 819–29.
   Web of Science ®Google Scholar
• Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients. Clin Infect Dis. 2015; 61: 871–8.
   PubMed Web of Science ®Google Scholar
• Rincon S, Panesso D, Diaz L, Carvajal LP, Reyes J, Munita JM, etal. Resistance to ‘last resort’ antibiotics in Gram-positive cocci: the post-vancomycin era. Biomedica. 2014; 34(Suppl 1): 191–208.
   Web of Science ®Google Scholar
• Johnson AP, Tysall L, Stockdale MV, Woodford N, Kaufmann ME, Warner M, etal. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis. 2002; 21: 751–4.
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Lolans K, Quinn JP. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis. 2005; 41: 565–6.
   PubMed Web of Science ®Google Scholar
• Talebi M, Asghari Moghadam N, Mamooii Z, Enayati M, Saifi M, Pourshafie MR. Antibiotic resistance and biofilm formation of Enterococcus faecalis in patient and environmental samples. Jundishapur J Microbiol. 2015; 8: e23349.
   Web of Science ®Google Scholar
• Rocas IN, Siqueira JF Jr., Santos KR. Association of Enterococcus faecalis with different forms of periradicular diseases. J Endod. 2004; 30: 315–20.
   PubMed Web of Science ®Google Scholar
• Zhang C, Du J, Peng Z. Correlation between Enterococcus faecalis and persistent intraradicular infection compared with primary intraradicular infection: a systematic review. J Endod. 2015; 41: 1207–13.
   PubMed Web of Science ®Google Scholar
• Tennert C, Fuhrmann M, Wittmer A, Karygianni L, Altenburger MJ, Pelz K, etal. New bacterial composition in primary and persistent/secondary endodontic infections with respect to clinical and radiographic findings. J Endod. 2014; 40: 670–7.
   Web of Science ®Google Scholar
• Stuart CH, Schwartz SA, Beeson TJ, Owatz CB. Enterococcus faecalis: its role in root canal treatment failure and current concepts in retreatment. J Endod. 2006; 32: 93–8.
   PubMed Web of Science ®Google Scholar
• Narayanan LL, Vaishnavi C. Endodontic microbiology. J Conserv Dent. 2010; 13: 233–9.
   PubMedGoogle Scholar
• Al-Nazhan S, Al-Sulaiman A, Al-Rasheed F, Alnajjar F, Al-Abdulwahab B, Al-Badah A. Microorganism penetration in dentinal tubules of instrumented and retreated root canal walls. In vitro SEM study. Restor Dent Endod. 2014; 39: 258–64.
   Google Scholar
• Souto R, Colombo AP. Prevalence of Enterococcus faecalis in subgingival biofilm and saliva of subjects with chronic periodontal infection. Arch Oral Biol. 2008; 53: 155–60.
   Web of Science ®Google Scholar
• Love RM. Enterococcus faecalis – a mechanism for its role in endodontic failure. Int Endod J. 2001; 34: 399–405.
   PubMed Web of Science ®Google Scholar
• Wang QQ, Zhang CF, Chu CH, Zhu XF. Prevalence of Enterococcus faecalis in saliva and filled root canals of teeth associated with apical periodontitis. Int J Oral Sci. 2012; 4: 19–23.
   PubMed Web of Science ®Google Scholar
• Berutti E, Marini R, Angeretti A. Penetration ability of different irrigants into dentinal tubules. J Endod. 1997; 23: 725–7.
   PubMed Web of Science ®Google Scholar
• Zou L, Shen Y, Li W, Haapasalo M. Penetration of sodium hypochlorite into dentin. J Endod. 2010; 36: 793–6.
   PubMed Web of Science ®Google Scholar
• Chavez De Paz LE, Dahlen G, Molander A, Moller A, Bergenholtz G. Bacteria recovered from teeth with apical periodontitis after antimicrobial endodontic treatment. Int Endod J. 2003; 36: 500–8.
   PubMed Web of Science ®Google Scholar
• Distel JW, Hatton JF, Gillespie MJ. Biofilm formation in medicated root canals. J Endod. 2002; 28: 689–93.
   Web of Science ®Google Scholar
• Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol. 2000; 54: 413–37.
   PubMed Web of Science ®Google Scholar
• Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000; 64: 847–67.
   PubMed Web of Science ®Google Scholar
• de la Fuente-Nunez C, Reffuveille F, Fernandez L, Hancock RE. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol. 2013; 16: 580–9.
   PubMed Web of Science ®Google Scholar
• Toledo-Arana A, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M, etal. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol. 2001; 67: 4538–45.
   PubMed Web of Science ®Google Scholar
• Pan J, Sun K, Liang Y, Sun P, Yang X, Wang J, etal. Cold plasma therapy of a tooth root canal infected with Enterococcus faecalis biofilms in vitro . J Endod. 2013; 39: 105–10.
   PubMed Web of Science ®Google Scholar
• Shen Y, Stojicic S, Haapasalo M. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development. J Endod. 2011; 37: 657–61.
   PubMed Web of Science ®Google Scholar
• Ricucci D, Siqueira JF Jr., Bate AL, Pitt Ford TR. Histologic investigation of root canal-treated teeth with apical periodontitis: a retrospective study from twenty-four patients. J Endod. 2009; 35: 493–502.
   PubMed Web of Science ®Google Scholar
• Vieira AR, Siqueira JF Jr., Ricucci D, Lopes WS. Dentinal tubule infection as the cause of recurrent disease and late endodontic treatment failure: a case report. J Endod. 2012; 38: 250–4.
   PubMed Web of Science ®Google Scholar
• Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37: 1771–6.
   PubMed Web of Science ®Google Scholar
• Lin J, Shen Y, Haapasalo M. A comparative study of biofilm removal with hand, rotary nickel-titanium, and self-adjusting file instrumentation using a novel in vitro biofilm model. J Endod. 2013; 39: 658–63.
   Web of Science ®Google Scholar
• Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011; 1: 111–14.
   PubMedGoogle Scholar
• Ly-Chatain MH. The factors affecting effectiveness of treatment in phages therapy. Front Microbiol. 2014; 5: 51.
   PubMed Web of Science ®Google Scholar
• Capparelli R, Nocerino N, Iannaccone M, Ercolini D, Parlato M, Chiara M, etal. Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis. 2010; 201: 52–61.
   PubMed Web of Science ®Google Scholar
• Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011; 1: 31–45.
   PubMedGoogle Scholar
• Stambolis C. [On the nature and significance of nodular renal blastoma (author's transl)]. Zentralbl Allg Pathol. 1979; 123: 3–8.
   Google Scholar
• Cornelissen A, Ceyssens PJ, T'Syen J, Van Praet H, Noben JP, Shaburova OV, etal. The T7-related Pseudomonas putida phage phi15 displays virion-associated biofilm degradation properties. PLoS One. 2011; 6: e18597.
   PubMed Web of Science ®Google Scholar
• Hughes KA, Sutherland IW, Clark J, Jones MV. Bacteriophage and associated polysaccharide depolymerases – novel tools for study of bacterial biofilms. J Appl Microbiol. 1998; 85: 583–90.
   PubMed Web of Science ®Google Scholar
• Hughes KA, Sutherland IW, Jones MV. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology. 1998; 144: 3039–47.
   PubMed Web of Science ®Google Scholar
• Vivaldi EA. [Informatics in the School of Medicine of the University of Chile. II. The school network and access to data bases]. Rev Med Chil. 1990; 118: 1387–92.
   Web of Science ®Google Scholar
• Gutierrez D, Vandenheuvel D, Martinez B, Rodriguez A, Lavigne R, Garcia P. Two phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms. Appl Environ Microbiol. 2015; 81: 3336–48.
   Web of Science ®Google Scholar
• Lu TK, Collins JJ. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci USA. 2007; 104: 11197–202.
   PubMed Web of Science ®Google Scholar
• Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother. 2010; 54: 397–404.
   PubMed Web of Science ®Google Scholar
• Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, etal. Bacteriophages phiMR299-2 and phiNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio. 2012; 3: e00029–12.
   PubMed Web of Science ®Google Scholar
• Basu S, Agarwal M, Kumar Bhartiya S, Nath G, Kumar Shukla V. An in vivo wound model utilizing bacteriophage therapy of Pseudomonas aeruginosa biofilms. Ostomy Wound Manage. 2015; 61: 16–23.
   PubMed Web of Science ®Google Scholar
• Nzakizwanayo J, Hanin A, Alves DR, McCutcheon B, Dedi C, Salvage J, etal. Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis . Antimicrob Agents Chemother. 2015; 60: 1530–6.
   PubMed Web of Science ®Google Scholar
• Curtin JJ, Donlan RM. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis . Antimicrob Agents Chemother. 2006; 50: 1268–75.
   PubMed Web of Science ®Google Scholar
• Seth AK, Geringer MR, Nguyen KT, Agnew SP, Dumanian Z, Galiano RD, etal. Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care. Plast Reconstr Surg. 2013; 131: 225–34.
   Google Scholar
• Sillankorva S, Oliveira D, Moura A, Henriques M, Faustino A, Nicolau A, etal. Efficacy of a broad host range lytic bacteriophage against Escherichia coli adhered to urothelium. Curr Microbiol. 2011; 62: 1128–32.
   PubMed Web of Science ®Google Scholar
• Ahiwale S, Tamboli N, Thorat K, Kulkarni R, Ackermann H, Kapadnis B. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage. Curr Microbiol. 2011; 62: 335–40.
   PubMed Web of Science ®Google Scholar
• Sillankorva S, Oliveira R, Vieira MJ, Azeredo J. Real-time quantification of Pseudomonas fluorescens cell removal from glass surfaces due to bacteriophage varphiS1 application. J Appl Microbiol. 2008; 105: 196–202.
   PubMed Web of Science ®Google Scholar
• Yilmaz C, Colak M, Yilmaz BC, Ersoz G, Kutateladze M, Gozlugol M. Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am. 2013; 95: 117–25.
   PubMed Web of Science ®Google Scholar
• Rahman M, Kim S, Kim SM, Seol SY, Kim J. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling. 2011; 27: 1087–93.
   PubMed Web of Science ®Google Scholar
• Phee A, Bondy-Denomy J, Kishen A, Basrani B. Azarpazhooh A, Maxwell K. Efficacy of bacteriophage treatment on Pseudomonas aeruginosa biofilms. J Endod. 2013; 39: 364–9.
   Web of Science ®Google Scholar
• Paisano AF, Spira B, Cai S, Bombana AC. In vitro antimicrobial effect of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212. Oral Microbiol Immunol. 2004; 19: 327–30.
   Google Scholar
• Summers WC. Felix d'Herelle and the origins of molecular biology. 1999; New Haven, CT: Yale University Press.
   Google Scholar
• Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, etal. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol. 2010; 11: 69–86.
   PubMed Web of Science ®Google Scholar
• Kutter EM, Kuhl SJ, Abedon ST. Re-establishing a place for phage therapy in Western medicine. Future Microbiol. 2015; 10: 685–8.
   PubMed Web of Science ®Google Scholar
• Fadlallah A, Chelala E, Legeais JM. Corneal infection therapy with topical bacteriophage administration. Open Ophthalmol J. 2015; 9: 167–8.
   PubMed Web of Science ®Google Scholar
• Brussow H. What is needed for phage therapy to become a reality in Western medicine?. Virology. 2012; 434: 138–42.
   PubMed Web of Science ®Google Scholar
• Bruttin A, Brussow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005; 49: 2874–8.
   PubMed Web of Science ®Google Scholar
• Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, etal. Experimental phage therapy of burn wound infection: difficult first steps. Int J Burns Trauma. 2014; 4: 66–73.
   PubMedGoogle Scholar
• Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, etal. Oral phage therapy of acute bacterial iarrhea with two coliphage preparations: a andomized trial in children from Bangladesh. EBioMedicine. 2016; 4: 124–37.
   PubMed Web of Science ®Google Scholar
• Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage. 2011; 66–85.
   Google Scholar
• Casas V, Maloy S. Role of bacteriophage-encoded exotoxins in the evolution of bacterial pathogens. Future Microbiol. 2011; 6: 1461–73.
   PubMed Web of Science ®Google Scholar
• Abedon ST, Lejeune JT. Why bacteriophage encode exotoxins and other virulence factors. Evol Bioinform Online. 2005; 1: 97–110.
   Web of Science ®Google Scholar
• Casas V, Magbanua J, Sobrepena G, Kelley ST, Maloy SR. Reservoir of bacterial exotoxin genes in the environment. Int J Microbiol. 2010; 2010: 754368.
   Google Scholar
• Abedon ST, Thomas-Abedon C. Phage therapy pharmacology. Curr Pharm Biotechnol. 2010; 11: 28–47.
   PubMed Web of Science ®Google Scholar
• Zhang W, Mi Z, Yin X, Fan H, An X, Zhang Z, etal. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. PLoS One. 2013; 8: e80435.
   PubMed Web of Science ®Google Scholar
• Uchiyama J, Rashel M, Takemura I, Wakiguchi H, Matsuzaki S. In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol. 2008; 74: 4149–63.
   PubMed Web of Science ®Google Scholar
• Ladero V, Gomez-Sordo C, Sanchez-Llana E, Del Rio B, Redruello B, Fernandez M, etal. Q69 (an Enterococcus faecalis-Infecting Bacteriophage) as a biocontrol agent for reducing tyramine in dairy products. Front Microbiol. 2016; 7: 445.
   Web of Science ®Google Scholar
• Uchiyama J, Rashel M, Maeda Y, Takemura I, Sugihara S, Akechi K, etal. Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate. FEMS Microbiol Lett. 2008; 278: 200–6.
   Web of Science ®Google Scholar
• Horiuchi T, Sakka M, Hayashi A, Shimada T, Kimura T, Sakka K. Complete genome sequence of bacteriophage BC-611 specifically infecting Enterococcus faecalis strain NP-10011. J Virol. 2012; 86: 9538–9.
   Web of Science ®Google Scholar
• Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, etal. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol. 2015; 81: 2696–705.
   PubMed Web of Science ®Google Scholar
• Khalifa L, Coppenhagen-Glazer S, Shlezinger M, Kott-Gutkowski M, Adini O, Beyth N, etal. Complete genome sequence of Enterococcus bacteriophage EFLK1. Genome Announc. 2015; 3: e01308–15.
   Google Scholar
• Parasion S, Kwiatek M, Mizak L, Gryko R, Bartoszcze M, Kocik J. Isolation and characterization of a novel bacteriophage phi4D lytic against Enterococcus faecalis strains. Curr Microbiol. 2012; 65: 284–9.
   Web of Science ®Google Scholar
• Li X, Ding P, Han C, Fan H, Wang Y, Mi Z, etal. Genome analysis of Enterococcus faecalis bacteriophage IME-EF3 harboring a putative metallo-beta-lactamase gene. Virus Genes. 2014; 49: 145–51.
   Web of Science ®Google Scholar
• Fard RM, Barton MD, Arthur JL, Heuzenroeder MW. Whole-genome sequencing and gene mapping of a newly isolated lytic enterococcal bacteriophage EFRM31. Arch Virol. 2010; 155: 1887–91.
   Web of Science ®Google Scholar
• Yasmin A, Kenny JG, Shankar J, Darby AC, Hall N, Edwards C, etal. Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages. J Bacteriol. 2010; 192: 1122–30.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Chang HI. Genomic annotation for the temperate phage EFC-1, isolated from Enterococcus faecalis KBL101. Arch Virol. 2015; 160: 601–4.
   Web of Science ®Google Scholar
• Stevens RH, Ektefaie MR, Fouts DE. The annotated complete DNA sequence of Enterococcus faecalis bacteriophage phiEf11 and its comparison with all available phage and predicted prophage genomes. FEMS Microbiol Lett. 2011; 317: 9–26.
   Web of Science ®Google Scholar
• Rigvava S, Tchgkonia I, Jgenti D, Dvalidze T, Carpino J, Goderdzishvili M. Comparative analysis of the biological and physical properties of Enterococcus faecalis bacteriophage vB_EfaS_GEC-EfS_3 and Streptococcus mitis bacteriophage vB_SmM_GEC-SmitisM_2. Can J Microbiol. 2013; 59: 18–21.
   Web of Science ®Google Scholar
• Young-Woo K, Hyo-Thl C. Isolation and molecular characterization of ΦFC1,a new temperate phage from Enterococcus faecalis . Mol Cell. 1994; 4: 155–8.
   Google Scholar
• Nigutova K, Styriak I, Javorsky P, Pristas P. Partial characterization of Enterococcus faecalis bacteriophage F4. Folia Microbiol (Praha). 2008; 53: 234–6.
   Web of Science ®Google Scholar
• Wolanek GA, Loushine RJ, Weller RN, Kimbrough WF, Volkmann KR. In vitro bacterial penetration of endodontically treated teeth coronally sealed with a dentin bonding agent. J Endod. 2001; 27: 354–7.
   Web of Science ®Google Scholar
• Chavez de Paz LE. Redefining the persistent infection in root canals: possible role of biofilm communities. J Endod. 2007; 33: 652–62.
   PubMed Web of Science ®Google Scholar
• Saber Sel D, El-Hady SA. Development of an intracanal mature Enterococcus faecalis biofilm and its susceptibility to some antimicrobial intracanal medications; an in vitro study. Eur J Dent. 2012; 6: 43–50.
   Google Scholar
• Sime-Ngando T. Environmental bacteriophages: viruses of microbes in aquatic ecosystems. Front Microbiol. 2014; 5: 355.
   Web of Science ®Google Scholar
• Shapiro OH, Kushmaro A. Bacteriophage ecology in environmental biotechnology processes. Curr Opin Biotechnol. 2011; 22: 449–55.
   Web of Science ®Google Scholar